PegBio Co., Ltd. filed its Monthly Return for the period ended 30 September 2026, confirming that both authorised (registered) and issued share capital remained unchanged throughout the month.

PegBio’s registered share capital stood at RMB 391.09 million, comprising 386.00 million H shares and 5.09 million unlisted domestic shares, each with a par value of RMB 1. No increases, decreases, or cancellations were recorded during the reporting period.

Issued share capital mirrored the registered totals: 386.00 million H shares and 5.09 million unlisted shares, with zero treasury shares outstanding. The company reported no movements in share options, warrants, convertibles, or other equity-linked instruments.

PegBio confirmed that the minimum public-float requirement of 25 percent for its H-share class was met as at 30 September 2026, based on publicly available information.

The filing was signed by Joint Company Secretary Huang Yifeng and submitted to Hong Kong Exchanges and Clearing Limited on 7 October 2026.